German Commercial Services Stock News

It looks like Daimler Truck Holding AG ( ETR:DTG ) is about to go ex-dividend in the next 4 days. The ex-dividend date...

adidas AG ( ETR:ADS ) just released its latest first-quarter results and things are looking bullish. Results were good...

If you are wondering whether Deutsche Lufthansa’s €7.33 share price offers value or risk at today’s levels, key clues sit in how the market is currently weighing its fundamentals. The stock has returned 1.1% over the last 7 days, while the 30 day performance is a 2.3% decline and the year to date move is a 14.6% decline, set against an 18.9% gain over the past year and a 12.6% decline over 3 years. Investors have been reacting to ongoing sector wide themes such as capacity planning, cost...

Merck KGaA (XTRA:MRK) announced a collaboration with Remepy to develop Hybrid Drugs that pair pharmaceuticals with app-based digital therapeutics for rare and difficult-to-treat cancers. The company also introduced its first bio-based solvent portfolio for high-performance liquid chromatography, aimed at supporting more sustainable laboratory operations. For you as an investor, these moves highlight how Merck KGaA is leaning into two active themes in healthcare: digital therapeutics and...

Regular readers will know that we love our dividends at Simply Wall St, which is why it's exciting to see BASF SE...

PUMA (XTRA:PUM) has just posted its Q1 2026 scorecard, and investors are coming off a volatile 2025 where quarterly revenue moved from €2.08b in Q1 to €1.56b in Q4 while EPS swung from a small profit of essentially €0.00 in Q1 to a loss of €2.28 per share in Q4. Over the same stretch, net income shifted from a €0.5m profit in Q1 2025 to a €336.3m loss by Q4 as revenue stepped down from €2.31b in Q3 2024 to €1.56b in Q4 2025, which puts the spotlight firmly on how much of each euro of sales is...

If you are wondering whether Allianz is fairly priced or has more room to run, an effective starting point is to look closely at what the current share price implies about its value. The stock recently closed at €389.00, with returns of 8.3% over 30 days, 11.4% over 1 year and 123.1% over 5 years. These figures can influence how much risk and upside investors feel is still on the table. Recent coverage around Allianz has focused on its position as a large European insurer, its capital...

Regular readers will know that we love our dividends at Simply Wall St, which is why it's exciting to see SAP SE...

Readers hoping to buy Deutsche Post AG ( ETR:DHL ) for its dividend will need to make their move shortly, as the stock...

Deutsche Bank (XTRA:DBK) has opened Q1 2026 earnings season with context set by Q4 2025 figures of €6.7b in revenue, basic EPS of €0.21 and net income of €416m, alongside a trailing twelve month EPS of €2.99 on revenue of €29.7b and net income of €5.8b. Over the past few quarters, revenue has ranged from €7.0b to €7.8b, while quarterly basic EPS moved between €0.21 and €1.00 and net income between €416m and €1.97b. This gives investors a clearer view of how profitability is tracking into the...

Nagarro (XTRA:NA9) has put fresh numbers on the table for FY 2025, with Q3 revenue of €254.6 million and basic EPS of €1.69, while trailing 12 month revenue stands at about €1.0 billion and EPS at €3.76. Over recent quarters, revenue has moved from €244.2 million in Q2 2024 to €252.0 million in Q2 2025, and from €246.7 million in Q4 2024 to €254.6 million in Q3 2025. EPS shifted from €0.90 and €0.59 in those 2024 quarters to €0.65 and €1.69 in the latest 2025 prints. For you as an investor,...

Wondering whether Dr. Ing. h.c. F. Porsche is attractively priced today or just looks cheap on the surface? This article walks through the numbers so you can judge how the current share price lines up with its underlying value. The stock last closed at €40.53, with returns of 6.6% over the past month but a 14.9% decline year to date and a 3.2% decline over the past year, which may have shifted how the market views its risk and reward trade off. Recent headlines around Dr. Ing. h.c. F...

Recent interest in innoscripta (XTRA:1INN) has been sparked by two corporate moves: the relocation of its registered seat to Tutzing and a fresh push into the French R&D tax incentive market via Toulouse. See our latest analysis for innoscripta. These corporate moves come after a mixed stretch for the stock, with a 30 day share price return of 9.65% offset by a 21.43% decline year to date. This suggests that recent momentum is picking up from a weaker few months. If you are curious about what...

At its Annual General Meeting on April 23, 2026, E.ON SE shareholders approved a €0.57 per share dividend for fiscal 2025 and elected Helene von Roeder and Dr. Dominik von Achten to the Supervisory Board. The addition of two senior executives from large German industrial groups may broaden E.ON’s oversight expertise as it manages capital-intensive grid investments and regulatory complexity. With the newly approved €0.57 dividend and fresh Supervisory Board expertise, we’ll now examine how...

As European markets navigate recent declines, with the STOXX Europe 600 Index down 2.54% and major indices like Germany's DAX and France's CAC 40 experiencing notable drops, investors are increasingly focused on defensive sectors amid geopolitical tensions. In this environment, identifying promising small-cap stocks that can withstand market volatility becomes crucial; these "undiscovered gems" often offer unique growth opportunities driven by innovative business models or niche market...

We feel now is a pretty good time to analyse Singulus Technologies AG's ( ETR:SNG ) business as it appears the company...

Nordex (XTRA:NDX1) has opened Q1 2026 reporting season with a reference point of €2.54b in Q4 2025 revenue and basic EPS of €0.78, capping a trailing twelve month period where EPS reached €1.16 and revenue came in at about €7.55b. Over recent quarters, the company has seen revenue move from €2.19b in Q4 2024 to €2.54b in Q4 2025 while basic EPS shifted from €0.07 to €0.78, alongside trailing year net income of €274.45m. This has set up a results story where higher profitability and a 3.6% net...

As geopolitical tensions and economic uncertainties weigh on European markets, the pan-European STOXX Europe 600 Index has recently experienced a decline, with defensive sectors like utilities and telecoms showing relative strength. In this environment, identifying undervalued stocks becomes crucial for investors seeking opportunities to capitalize on potential market mispricings.

Readers hoping to buy GEA Group Aktiengesellschaft ( ETR:G1A ) for its dividend will need to make their move shortly...

Wondering whether Fresenius Medical Care at around €38.84 is starting to look attractive or still expensive compared to its fundamentals? This article focuses squarely on what you are getting for the current price. The stock has been relatively muted in the short term, with a 1.8% decline over the last 7 days and a 1.1% gain over the last 30 days, while the 1 year return sits at a 6.9% decline and the 5 year return at a 33.4% decline. Recent coverage around Fresenius Medical Care has largely...

Wondering if PUMA at around €25 a share still offers value, or if the easy gains are already behind it? This article walks through what the current price may be implying about the business. The stock has returned 13.8% over the last 30 days and 11.6% year to date, although the 12.9% return over the last year sits against a much weaker 3 year return of 49.8% and a 5 year return of 69.3%. Recent coverage has focused on how PUMA fits into the global sportswear and athleisure space, including...

How SAP (XTRA:SAP) Entered Q1 2026 on the Back of Its Recent Numbers SAP (XTRA:SAP) heads into its Q1 2026 reporting cycle with investors already digesting recent quarterly figures, including Q4 2025 revenue of about €9.7b and basic EPS of €1.44. Over the last six reported quarters, the company has seen revenue move from €8.5b in Q3 2024 to €9.7b in Q4 2025, while basic EPS over that same span ranged between €1.25 and €1.72 per quarter. This gives a clear view of how the top and bottom line...

If you are wondering whether AIXTRON's share price still offers value or if the opportunity has already passed, this article walks through what the current valuation signals actually say. AIXTRON's stock has recently closed at €46.57, with returns of 5.2% over 7 days, 27.3% over 30 days, 137.7% year to date, and 319.8% over 1 year. This naturally raises questions about how much of the story is already priced in. Recent coverage has focused on AIXTRON's position in the semiconductor equipment...

There's been a major selloff in flatexDEGIRO SE ( ETR:FTK ) shares in the week since it released its first-quarter...